Key statistics
On Thursday, Ligand Pharmaceuticals Inc (LGNDZ:PKC) closed at 0.0022, 29.41% above the 52 week low of 0.0017 set on Dec 14, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.0022 |
---|---|
High | 0.0022 |
Low | 0.0022 |
Bid | -- |
Offer | -- |
Previous close | 0.0022 |
Average volume | 1.20k |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Nov 14 2024 17:07 GMT.
More ▼
Press releases
- Ligand to Present at Stifel 2024 Healthcare Conference
- Ligand Reports Third Quarter 2024 Financial Results and Raises 2024 Guidance
- Ligand to Host Investor and Analyst Day on December 10, 2024 in Boston
- Ligand to Report Third Quarter 2024 Financial Results on November 7, 2024
- Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy
More ▼